Third trimester maternal plasma total fibronectin levels in pregnancy-induced hypertension: Results of a tertiary center

Clinical and Applied Thrombosis/Hemostasis

Volumn 12, Issue 1, 2006, Pages 33-39

  Aydin, Tahsin ^a   Varol, Füsun G ^b   Sayin, Niyazi Cenk ^b  

^a SSK Buca Hospital   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

Author keywords

Fibronectin; Gestational hypertension; Preeclampsia; Turkish population

Indexed keywords

FIBRONECTIN;

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNODIFFUSION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL PLASMA; MEAN ARTERIAL PRESSURE; PREECLAMPSIA; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY;

ADULT; CASE-CONTROL STUDIES; FEMALE; FIBRONECTINS; GESTATIONAL AGE; HUMANS; HYPERTENSION; IMMUNODIFFUSION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 32344435666     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960601200106     Document Type: Article

References (29)

1. Sibai BM. Medical disorders during pregnancy including hypertensive disorders. Curr Opin Obstet Gynecol 1991;3:28.
2. Miyamoto S, Katz BZ, Lafrenie RM, et al. Fibronectin and integrins in cell adhesion, signaling, and morphogenesis. Ann NY Acad Sci 1998;857:119.
3. Mosher DF. Physiology of fibronectin. Ann Rev Med 1984;35:561.
4. Redman CW, Sacks GP, Sargent IL. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499.
5. Ballegeer V, Spitz B, Kietevls L, et al. Predictive value of increased plasma levels of fibronectin in gestational hypertension. Am J Obstet Gynecol 1989;161:432.
6. Paternoster DM, Stella A, Simioni P, et al. Fibronectin and antithrombin as markers of pre-eclampsia in pregnancy. Eur J Obstet Gynecol Reprod Biol 1996;70:33.
7. Eriksen HO, Hansen KP, Brocks V, et al. Plasma fibronectin concentration in normal pregnancy and preeclampsia. Acta Obstet Gynecol Scand 1987;66:25.
8. Paternoster D, Stella A, Simioni P, et al. Clotting inhibitors and fibronectin as potential markers in preeclampsia. Int J Gynaecol Obstet 1994;47:215.
9. Friedman SA, de Groot CJ, Taylor RN, et al. Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol 1994;170:838.
10. Gredmark T, Bergman B, Hellström L. Total fibronectin in maternal plasma as a predictor for preeclampsia. Gynecol Obstet Invest 1999;47:89.
11. Lazarchick J, Stubbs TM, Romein L, et al. Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. Am J Obstet Gynecol 1986;154:1050.
12. Paarlberg KM, de Jong CL, van Geijn HP, et al. Total plasma fibronectin as a marker of pregnancy-induced hypertensive disorders: A longitudinal study. Obstet Gynecol 1998;91:383.
13. Taylor RN, Crombleholme WR, Freidman SA, et al. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but can not be attributed to hypertension alone. Am J Obstet Gynecol 1991;165:895.
14. Madazli R, Budak E, Calay Z, et al. Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in pre-eclampsia. Br J Obstet Gynaecol 2000;107:514.
15. Chavarria ME, Lara-Gonzalez L, Gonzalez-Gleason A, et al. Maternal plasma cellular fibronectin concentrations in normal and preeclamptic pregnancies: A longitudinal study for early prediction of preeclampsia. Am J Obstet Gynecol 2002;187:595.
16. Lockwood CJ, Peters JH. Increased plasma levels of ED1+ cellular fibronectin precede the clinical sign of preeclampsia. Am J Obstet Gynecol 1990;162:35.
17. Sud SS, Gupta I, Dhaliwal LK, et al. Serial plasma fibronectin levels in pre-eclamptic and normotensive women. Int J Gynecol Obstet 1999;66:123.
18. National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Nat Inst Health 2000:3029.
19. Villar I, Sibai BM. Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or diastolic pressure during third trimester. Am J Obstet Gynecol 1989;160:419.
20. ACOG technical bulletin. Hypertension in pregnancy. Number 219-January 1996 (replaces no. 91, February 1986). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1996;53:175.
21. Linnala A, Balza E, Zardi L, et al. Human amnion epithelial cells assemble tenascins and three fibronectin isoforms in the extracellular matrix. FEBS Lett 1993;317:74.
22. Saleh AA, Bottoms SF, Welch RA, et al. Preeclampsia, delivery and the hemostatic system. Am J Obstet Gynecol 1987;157:331.
23. Friedman SA, Schiff E, Emeis JJ, et al. Fetal plasma levels of cellular fibronectin as a measure of fetal endothelial involvement in preeclampsia. Obstet Gynecol 1997;89:46.
24. Stubbs TM, Lazarchick J, Holger EO 3rd. Plasma fibronectin levels in preeclampsia: A possible biochemical marker for vascular endothelial damage. Am J Obstet Gynecol 1984;150:885.
25. Deng L, Bremme K, Hansson LO, et al. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol 1994;84:941.
26. Brubaker DB, Ross MG, Marinoff D. The function of elevated plasma fibronectin in preeclampsia. Am J Obstet Gynecol 1992;166:526.
27. Bellart J, Gilabert R, Miralles RM, et al. Endothelial cell markers of fibrinopeptide A to D-Dimer ratio as a measure of the coagulation and fibrinolysis balance in normal pregnancy. Gynecol Obstet Invest 1998;46:17.
28. Akgül C, Salmayenli N, Ibrahimoglu L. Plasma fibronectin levels and preeclampsia. Int J Gynaecol Obstet 1994;44:280.
29. Tamas P, Feledi E, Ertl T, et al. Maternal plasma fibronectin and neonatal birth weight. Gynecol Obstet Invest 1992;33:124.